Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR1 | P30872 | 6/20 | 0.44 |
| ▸ | SSTR2 | P30874 | 6/20 | 0.44 |
| ▸ | SSTR4 | P31391 | 6/20 | 0.44 |
| ▸ | SSTR3 | P32745 | 6/20 | 0.44 |
| ▸ | SSTR5 | P35346 | 6/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.43 |
| ▸ | CDC25B | P30305 | 6/20 | 0.43 |
| ▸ | SELP | P16109 | 2/20 | 0.39 |
| ▸ | TACR1 | P25103 | 2/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.37 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21914162 | 0.80 | SSTR4 (0.67) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL20019605 | 0.77 | SELP (0.59) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL20019557 | 0.77 | SELP (0.59) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL21915005 | 0.76 | SELP (0.43) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL21915001 | 0.76 | SSTR4 (0.51) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL10314149 | 0.75 | PTPN1 (0.49) | PTPN1CDC25BSELPPTPN2PTPN6 | |
| SCHEMBL21914263 | 0.74 | PTPN1 (0.43) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL21914253 | 0.74 | SELP (0.44) | SELP | |
| SCHEMBL21914272 | 0.73 | SSTR1 (0.38) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL10314146 | 0.72 | SELP (0.52) | PTPN1CDC25BSELPPTPN2PTPN6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10588962-B2 | Carbohydrate-glycolipid conjugate vaccines | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2020-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10588962-B2 | Carbohydrate-glycolipid conjugate vaccines | STT3B, STT3A, DDOST | SSTR1 3803/4885SSTR2 3510/4885SSTR4 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.